More on PFE
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $28.00 |
|
|||
| Open | $27.90 | ||||
| 52 Wk High | $37.39 | ||||
| 52 Wk Low | $28.25 | ||||
| Day High | $28.00 | ||||
| Day Low | $27.48 | ||||
| P/E | 16.80 | ||||
| EPS | $1.65 | ||||
| Volume | 14,238,640 | ||||
- Pfizer (PFE) PT Raised to $28 at Cantor Fitzgerald on Growing Sector Tailwinds
- FDA approves Pfizer's Tukysa as front-line maintenance for HER2+ breast cancer
- Pfizer’s TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancer
- Pfizer to cut 330 jobs at Sicily plant, unions say
- Pfizer (PFE) PT Raised to $33 at Scotiabank
- Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026
- Pfizer Declares Fourth-Quarter 2026 Dividend
- Pfizer's Litfulo meets Phase 3 endpoints for vitiligo treatment
- Pfizer’s LITFULO Significantly Improved Facial and Total Body Repigmentation in Patients with Nonsegmental Vitiligo
- Form 4 PFIZER INC For: Sep 30 Filed by: BOURLA ALBERT
Entities mentioned with PFE
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
